Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B

International Immunology

Volumn 19, Issue 2, 2007, Pages 133-140

  Yang, Guilin ^a,b   Liu, Ailian ^a   Xie, Qing ^c   Guo, Taylor B ^a   Wan, Bing ^a   Zhou, Boping ^b   Zhang, Jingwu Z ^a,d  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shenzhen Municipal Hospital of Infectious Diseases   (China)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^d Shanghai Institute of Immunology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ANTIBODY BLOOD LEVEL; ANTIGEN ANTIBODY REACTION; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HUMAN; IMMUNOLOGICAL TOLERANCE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD4; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 33846600414     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxl130     Document Type: Article

References (40)

1. Lai, C. L., Ratziu, V., Yuen, M. F. and Poynard, T. 2003. Viral hepatitis B. Lancet 362:2089.
2. Lee, W. M. 1997. Hepatitis B virus infection. N. Engl. J. Med. 337:1733.
3. Lai, C. L. 1997. Chronic hepatitis B in Hong Kong: Immunization strategies for the control of hepatitis B virus infection. In Zuckerman, A. J., ed., Hepatitis B in the Asian-Pacific Region. Vol. 1. Screening, Diagnosis and Control, p. 79. Royal College of Physicians, London.
4. Matthews, G. V. and Nelson, M. R. 2001. The management of chronic hepatitis B infection. Int. J. STD AIDS 12:353.
5. Guidotti, L. G. and Chisari, F. V. 2006. Immunobiology and pathogenesis of viral hepatitis. Annu. Rev. Pathol. Mech. Dis. 1:23.
6. Brechot, C. 2004. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: Old and new paradigms. Gastroenterology 127:S56.
7. Guidotti, L. G. and Chisari, F. V. 2001. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19:65.
8. Beasley, R. P. and Hwang, L. Y. 1991. Overview on the epidemiology of hepatocellular carcinoma. In Hollinger, F. B., Lemon, S. M. and Margolis, H., eds, Viral Hepatitis and Liver Diseases, p. 532. Williams and Wilkins, Baltimore.
9. de Jongh, F. E., Janssen, H. L., de Man, R. A. et al. 1992. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology 103:1630.
10. Schwartz, R. H. 2003. T cell anergy. Annu. Rev. Immunol. 21:305.
11. Chen, M., Sallberg, M., Hughes, J. et al. 2005. Immune tolerance split between hepatitis B virus precore and core proteins. J. Virol. 79:3016.
12. Ghoreishi, M. and Dutz, J. P. 2006. Tolerance induction by transcutaneous immunization through ultraviolet-irradiated skin is transferable through CD4+CD25+ T regulatory cells and is dependent on host-derived IL-10. J. Immunol. 176:2635.
13. Fucs, R., Jesus, J. T., Souza Junior, P. H. et al. 2006. Frequency of natural regulatory CD4+CD25+ T lymphocytes determines the outcome of tolerance across fully mismatched MHC barrier through linked recognition of self and allogeneic stimuli. J. Immunol. 176:2324.
14. Asiedu, C. K., Goodwin, K. J., Balgansuren, G. et al. 2005. Elevated T regulatory cells in long-term stable transplant tolerance in rhesus macaques induced by anti-CD3 immunotoxin and deoxyspergualin. J. Immunol. 175:8060.
15. Viglietta, V., Baecher-Allan, C., Weiner, H. L. and Hafler, D. A. 2004. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199:971.
16. Cao, D., Malmstrom, V., Baecher-Allan, C., Hafler, D., Klareskog, L. and Trollmo, C. 2003. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur. J. Immunol. 33:215.
17. Smyth, M. J., Teng, M. W., Swann, J., Kyparissoudis, K., Godfrey, D. I. and Hayakawa, Y. 2006. CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J. Immunol. 176:1582.
18. Rouse, B. T. and Suvas, S. 2004. Regulatory cells and infectious agents: detentes cordiale and contraire. J. Immunol. 173:2211.
19. Aandahl, E. M., Michaelsson, J., Moretto, W. J., Hecht, F. M. and Nixon, D. F. 2004. Human CD4+CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 78:2454.
20. Oswald-Richter, K., Grill, S. M., Shariat, N. et al. 2004. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PloS Biol. 2:E198.
21. Cabrera, R., Tu, Z., Xu, Y. et al. 2004. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40:1062.
22. Sugimoto, K., Ikeda, F., Stadanlick, J., Nunes, F. A., Alter, H. J. and Chang, K. M. 2003. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 38:1437.
23. Rushbrook, S. M., Ward, S. M., Unitt, E. et al. 2005. Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. J. Virol. 79:7852.
24. Stoop, J. N., van der Molen, R. G., Baan, C. C. et al. 2005. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 41:771.
25. Xu, D., Fu, J., Jin, L. et al. 2006. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J. Immunol. 177:739.
26. Chinese Society of Infectious Disease and Parasitology and Chinese Society of Hepatology of Chinese Medical Association 2000. The programme of prevention and cure for viral hepatitis. Zhonghua Gan Zang Bing Za Zhi 8:324.
27. Roncador, G., Garcia, J. F., Garcia, J. F. et al. 2005. FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma. Leukemia 19:2247.
28. Hori, S., Nomura, T. and Sakaguchi, S. 2003. Control of regulatory T cell development by the transcription factor FoxP3. Science 299:1057.
29. Fontenot, J. D., Gavin, M. A. and Rudensky, A. Y. 2003. FoxP3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4:330.
30. Khattri, R., Cox, T., Yasayko, S. A. and Ramsdell, F. 2003. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4:337.
31. Chen, W., Jin, W., Hardegen, N. et al. 2003. Conversion of peripheral CD4+CD25a naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198:1875.
32. Fantini, M. C., Becker, C., Monteleone, G., Pallone, F., Galle, P. R. and Neurath, M. F. 2004. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25a T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172:5149.
33. Zheng, S. G., Wang, J. H., Gray, J. D., Soucier, H. and Horwitz, D. A. 2004. Natural and induced CD4+CD25+ cells educate CD4+CD25a cells to develop suppressive activity: The role of IL-2, TGF-beta, and IL-10. J. Immunol. 172:5213.
34. Fantini, M. C., Becker, C., Tubbe, I. et al. 2006. Transforming growth factor beta induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis. Gut 55:671.
35. Vandenbark, A. A., Chou, Y. K., Whitham, R. et al. 1996. Treatment of multiple sclerosis with T-cell receptor peptides: Results of a double-blind pilot trial. Nat. Med. 2:1109.
36. Kumar, V., Aziz, F., Sercarz, E. and Miller, A. 1997. Regulatory T cells specific for the same framework 3 region of the Vbeta8.2 chain are involved in the control of collagen II-induced arthritis and experimental autoimmune encephalomyelitis. J. Exp. Med. 185:1725.
37. Liu, H., Komai-Koma, M., Xu, D. and Liew, F. Y. 2006. Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. Proc. Natl Acad. Sci. USA 103:7048.
38. Akpolat, N., Yahsi, S., Godekmerdan, A., Demirbag, K. and Yalniz, M. 2005. Relationship between serum cytokine levels and histopathological changes of liver in patients with hepatitis B. World J. Gastroenterol. 11:3260.
39. Calabrese, F., Valente, M., Giacometti, C. et al. 2003. Parenchymal transforming growth factor beta-1: Its type II receptor and Smad signaling pathway correlate with inflammation and fibrosis in chronic liver disease of viral etiology. J. Gastroenterol. Hepatol. 18:1302.
40. Kirmaz, C., Terzioglu, E., Topalak, O. et al. 2004. Serum transforming growth factor-beta1 (TGF-beta1) in patients with cirrhosis, chronic hepatitis B and chronic hepatitis C. Eur. Cytokine Netw. 15:112.